Explain this page
Arphra AIPlain-English read on Pfizer Inc.’s valuation06-03today
- Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth18h
- Is Pfizer's Discounted Valuation a Buying Opportunity or a Value Trap?20h
- Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know21h
- Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know4d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$77.72
+198.91% vs spot
Recommendation
Strong Buy
18 of 19 methods
Method spread
14bull3bear
±5% threshold
Analyst PT consensus: $26.75 (+2.88%)
Candlestick · 1Y
Open in chart workstation →PFE
26.21+7.42%H 28.75L 23.11MA50 26.59MA200 25.85Avg vol 48.4M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.80% | +0.81% | +2.65% | -2.29% | +1.84% | +4.42% | +6.56% | -35.10% | -33.84% | -21.07% | +5953.13% |
Insider · 30d
History →Bought
$527.31K
2 txns
Sold
$116.23K
2 txns
Net flow
+$411.09K
Aftermarket
LiveLast trade
$26.05
Bid
$25.00
60 sh
Ask
$26.15
206 sh
Spread
$1.150
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 Dec 2025 | $17.56B | -$1.65B | $-0.29 |
| Q3 Sep 2025 | $16.65B | $3.54B | $0.62 |
| Q2 Jun 2025 | $14.65B | $2.91B | $0.51 |
| Q1 Mar 2025 | $13.72B | $2.97B | $0.52 |
| Q4 Dec 2024 | $17.76B | $403M | $0.07 |
| Q3 Sep 2024 | $17.7B | $4.47B | $0.78 |
Sector & industry today
LiveSectors
- Financial Services+1.26%
- Utilities+0.83%
- Communication Services+0.46%
- Energy+0.45%
- Technology+0.34%
- Consumer Defensive-0.21%
- Industrials-0.32%
- Healthcare-0.39%
- Real Estate-0.67%
- Consumer Cyclical-0.94%
- Basic Materials-1.06%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General-0.68%
- Department Stores-6.26%
- Broadcasting-4.30%
- Education & Training Services-3.71%
- Medical - Equipment & Services+3.71%
- Solar-3.63%
- Electronic Gaming & Multimedia+3.56%
- Steel-3.33%
- Real Estate - Development-3.31%
- Trucking-3.16%
- Copper-3.02%
- Coal-2.91%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$26.75
+2.88% upside
Low
$25.00
Median
$27.00
High
$30.00
Recent actions
0 ↑0 ↓8 hold
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
- Dec 01, 2025
News
DB · news_items- Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growthfool.com·Jun 15, 2026
- Is Pfizer's Discounted Valuation a Buying Opportunity or a Value Trap?zacks.com·Jun 15, 2026
- Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Knowzacks.com·Jun 15, 2026
- Pfizer (PFE) Outpaces Stock Market Gains: What You Should Knowzacks.com·Jun 11, 2026
- This $25 Billion Acquisition Just Unlocked a New Era of Growth for Pfizer — and Why It's a Flawless Safe-Haven for Retirees247wallst.com·Jun 11, 2026
- A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25247wallst.com·Jun 11, 2026
- Why Pfizer Stock Popped Todayfool.com·Jun 11, 2026
- Pfizer CEO warns German investment at risk over drug pricing policiesreuters.com·Jun 10, 2026
Recent analyst activity
DB- Jun 09, 2026GradeUnderperform → Sector PerformPfizer upgraded to Sector Perform from Underperform at RBC CapitalRBC Capital
- Jun 01, 2026GradeNeutral → NeutralPfizer (PFE) Reiterates at Neutral by Cantor FitzgeraldCantor Fitzgerald
Peers
Total assets
$208.16B
Total debt
$67.42B
Cash & equiv
$1.14B
Operating CF
$11.71B
Free cash flow
$9.08B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
DAMICO JENNIFER B. officer: SVP & Controller | Sell | 2,000 | $51.4K | Jun 09, 2026 |
DAMICO JENNIFER B. officer: SVP & Controller | Sell | 2,500 | $64.83K | Mar 04, 2025 |
BLAYLOCK RONALD E director | Buy | 19,457 | $499.07K | Feb 13, 2025 |
Gottlieb Scott director | Buy | 1,000 | $28.24K | Oct 30, 2024 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $62.58B | $15.44B | $7.77B | $1.36 | +12.42% |
| FY 2024 | $63.63B | $16.48B | $8.02B | $1.41 | +12.60% |
| FY 2023 | $59.55B | $5.29B | $2.13B | $0.37 | +3.58% |
| FY 2022 | $100.33B | $37.55B | $31.37B | $5.47 | +31.26% |
| FY 2021 | $81.29B | $20.79B | $22.15B | $3.88 | +27.25% |